Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Project Impact 2: Culturally Tailored Smoking Cessation for Latino Smokers
NCT02596711Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2015
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Tobacco Use Disorder (TUD) (3 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Intervention Feasibility & Acceptability at 12 weeks, Patch Adherence: Percentage of Days With Patch at 12 weeks and 1 more. Started Nov 2015; status: completed.
02
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02596711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596711.